Anti-HA antibody does not detect hyaluronan

Area of Science:

• Biochemistry
• Histology
• Immunology

Background:

• Hyaluronic acid (HA) is a crucial biocompatible glycosaminoglycan in the extracellular matrix.
• HA's lack of immunogenicity is advantageous for therapeutics but hinders specific antibody production.
• Current research often uses anti-HA antibodies for immunohistochemical detection, despite potential specificity issues.

Purpose of the Study:

• To evaluate the specificity of anti-HA antibodies for detecting hyaluronic acid in histological samples.
• To compare the reliability of anti-HA antibodies versus a biotinylated HA binding protein (bHABP) probe for HA detection.

Main Methods:

• Hyaluronidase treatment of histological samples to assess HA epitope accessibility.
• Competitive binding assays using HA oligosaccharides to test antibody and bHABP probe specificity.
• Histological staining to visualize target binding and evaluate detection accuracy.

Main Results:

• Both hyaluronidase treatment and competitive binding assays demonstrated insufficient specificity of the anti-HA antibody for hyaluronic acid.
• The biotinylated HA binding protein (bHABP) probe exhibited reliable binding to its target, confirming its specificity for HA.
• Histological staining results indicated that the bHABP probe is a superior method for HA detection compared to anti-HA antibodies.

Conclusions:

• The anti-HA antibody is not sufficiently specific for accurate hyaluronic acid detection in histological analyses.
• The bHABP probe provides a reliable and specific method for detecting hyaluronic acid in tissue samples.
• Previous research conclusions based on anti-HA antibody staining require reevaluation, and future use of these antibodies should be reconsidered.